مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Measuring process indicators and adverse events to assess the quality of care for inpatients with psychosis.

Authors : Vermeulen JM; Department of Psychiatry, Amsterdam UMC, Academic Medical Center, Amsterdam, The Netherlands.; van Rooijen G

Subjects: Quality Indicators, Health Care* ; Quality of Health Care*; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use

Source: Journal of mental health (Abingdon, England) [J Ment Health] 2021 Oct; Vol. 30 (5), pp. 564-570. Date of Electronic Publication: 2019 Nov 07.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9212352 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.

Authors : Ignjatović Ristić D; a Psychiatric Clinic, Clinical Center Kragujevac and Faculty of Medical Sciences , University of Kragujevac , Kragujevac , Serbia.; Cohen D

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Clozapine/Clozapine/Clozapine/*adverse effects ; Psychotic Disorders/Psychotic Disorders/Psychotic Disorders/*drug therapy

Source: Nordic journal of psychiatry [Nord J Psychiatry] 2018 Feb; Vol. 72 (2), pp. 124-129. Date of Electronic Publication: 2017 Nov 10.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100927567 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Prevalence of neuroleptic-induced movement disorders: an 8-year follow-up study in chronic schizophrenia inpatients.

Authors : Parksepp M; a Madis Parksepp, Department of Psychiatry , University of Tartu , Tartu , Estonia ;

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Dyskinesia, Drug-Induced/Dyskinesia, Drug-Induced/Dyskinesia, Drug-Induced/*epidemiology ; Schizophrenia/Schizophrenia/Schizophrenia/*drug therapy

Source: Nordic journal of psychiatry [Nord J Psychiatry] 2016 Oct; Vol. 70 (7), pp. 498-502. Date of Electronic Publication: 2016 Apr 19.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100927567 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Pharmacotherapy for schizophrenic inpatients in East Asia--changes and challenges.

Authors : Shinfuku N; Seinan Gakuin University, Fukuoka, Japan. ; Tan CH

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Inpatients/Inpatients/Inpatients/*statistics & numerical data ; Schizophrenia/Schizophrenia/Schizophrenia/*drug therapy

Source: International review of psychiatry (Abingdon, England) [Int Rev Psychiatry] 2008 Oct; Vol. 20 (5), pp. 460-8.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918131 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.

Authors : Sorensen L; Amgros I/S, Dampfaergevej 22, København Ø, Denmark. ; Nielsen B

Subjects: Evidence-Based Medicine* ; Patient Admission* ; Schizophrenic Psychology*

Source: Nordic journal of psychiatry [Nord J Psychiatry] 2008; Vol. 62 (3), pp. 242-9.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100927567 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Risperidone monotherapy in manic inpatients: an open label, multicentre trial.

Authors : Forsthoff A; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.; Grunze H

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use ; Bipolar Disorder/Bipolar Disorder/Bipolar Disorder/*drug therapy ; Risperidone/Risperidone/Risperidone/*therapeutic use

Source: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry [World J Biol Psychiatry] 2007; Vol. 8 (4), pp. 256-61.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101120023 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients.

Authors : Høiberg MP; Department of Psychiatry, Odense University Hospital, DK-5000, Odense C, Denmark.; Nielsen B

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Basal Ganglia Diseases/Basal Ganglia Diseases/Basal Ganglia Diseases/*chemically induced ; Basal Ganglia Diseases/Basal Ganglia Diseases/Basal Ganglia Diseases/*epidemiology

Source: Nordic journal of psychiatry [Nord J Psychiatry] 2006; Vol. 60 (3), pp. 207-12.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100927567 Publication Model: Print Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care.

Authors : Petersen AB; Department of Clinical Pharmacology, Bispebjerg Hospital , Copenhagen , Denmark.; Andersen SE

Subjects: Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Benzodiazepines/Benzodiazepines/Benzodiazepines/*adverse effects ; Psychotic Disorders/Psychotic Disorders/Psychotic Disorders/*complications

Source: Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2014 Jan; Vol. 52 (1), pp. 39-43. Date of Electronic Publication: 2013 Dec 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101241654 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.

Authors : Riedel M; Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany.; Mayr A

Subjects: Schizophrenic Psychology* ; Suicidal Ideation*; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use

Source: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry [World J Biol Psychiatry] 2012 Jan; Vol. 13 (1), pp. 30-8. Publisher: Informa Healthcare Country of Publication: England NLM ID: 101120023 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Medication for borderline personality disorder: a survey at a secure hospital.

Authors : Haw C; St Andrew's Healthcare, Northampton, UK. ; Stubbs J

Subjects: Off-Label Use*; Antidepressive Agents/Antidepressive Agents/Antidepressive Agents/*therapeutic use ; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*therapeutic use

Source: International journal of psychiatry in clinical practice [Int J Psychiatry Clin Pract] 2011 Nov; Vol. 15 (4), pp. 280-5. Date of Electronic Publication: 2011 Jul 11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9709509 Publication Model: Print-Electronic Cited

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Measuring process indicators and adverse events to assess the quality of care for inpatients with psychosis.

The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.

Prevalence of neuroleptic-induced movement disorders: an 8-year follow-up study in chronic schizophrenia inpatients.

Pharmacotherapy for schizophrenic inpatients in East Asia--changes and challenges.

Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.

Risperidone monotherapy in manic inpatients: an open label, multicentre trial.

Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients.

Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care.

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.

Medication for borderline personality disorder: a survey at a secure hospital.